<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03924804</url>
  </required_header>
  <id_info>
    <org_study_id>20190418</org_study_id>
    <nct_id>NCT03924804</nct_id>
  </id_info>
  <brief_title>Effect of Different Infusion Volume on Perioperative Bladder and Blood Volume in Patients Undergoing Daytime Surgery.</brief_title>
  <official_title>Effect of Different Infusion Volume on Perioperative Bladder and Blood Volume in Patients Undergoing Daytime Surgery.</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>China Medical University, China</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>China Medical University, China</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of the trial was to explore the effect of different infusion volume on&#xD;
      perioperative bladder and blood volume in patients undergoing daytime surgery assisted by&#xD;
      bladder and vascular ultrasound and transthoracic echocardiography.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The objective of the trial was to evaluate the effects of different infusion volume of&#xD;
      Ringer's solution acetate (2 ml/kg,8ml/kg, 16ml/kg) on bladder volume,&#xD;
      hemodynamics,transthoracic echocardiography and vascular ultrasound including the inferior&#xD;
      vena cava(IVC) and the right subclavian vein(SCV) diameter and the IVC and SCV collapsibility&#xD;
      index in patients undergoing daytime surgery through a randomized controlled clinical study,&#xD;
      so as to provide better guidance for clinical transfusion avoiding bladder catheterization .&#xD;
      The patients in this trial were visited before induction and discharge from the&#xD;
      postanaesthesia .We also collected the first time and times of micturition and whether the&#xD;
      patients have the dysuria.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Suspended</overall_status>
  <why_stopped>
    NO patients&#xD;
  </why_stopped>
  <start_date type="Actual">June 19, 2019</start_date>
  <completion_date type="Anticipated">September 30, 2022</completion_date>
  <primary_completion_date type="Anticipated">August 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <intervention_model_description>Doppler Ultrasonography Assessed Bladder and Blood Volume</intervention_model_description>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Triple (Participant, Investigator, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>1. The change of bladder volume</measure>
    <time_frame>baseline and 10 minutes before leaving the post-anesthesia care unite</time_frame>
    <description>bladder and blood volume in patients undergoing daytime surgery assisted by bladder and vascular ultrasound</description>
  </primary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Anticipated">90</enrollment>
  <condition>Cholecystolithiasis and Thyroid Nodule</condition>
  <arm_group>
    <arm_group_label>Group A: 2 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group B: 8 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>Group C: 16 ml/kg group</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's solution acetate</intervention_name>
    <description>Intravenous infusion of 2 ml/kg Ringer's solution acetate within 1 hour after induction.</description>
    <arm_group_label>Group A: 2 ml/kg group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's solution acetate</intervention_name>
    <description>Intravenous infusion of 8ml/kg Ringer's solution acetate within 1 hour after induction.</description>
    <arm_group_label>Group B: 8 ml/kg group</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Ringer's solution acetate</intervention_name>
    <description>Intravenous infusion of 16ml/kg Ringer's solution acetate within 1 hour after induction.</description>
    <arm_group_label>Group C: 16 ml/kg group</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  1. ethnic Chinese;&#xD;
&#xD;
          -  2. age, 18 to 65 years old;&#xD;
&#xD;
          -  3. American Society of Anaesthesiologists (ASA) physical status I or II;&#xD;
&#xD;
          -  4. Daytime patients scheduled for general anesthesia&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Patients unwilling to cooperate with the experiment&#xD;
&#xD;
          -  Body mass index exceeding 30 kg/m2;&#xD;
&#xD;
          -  Patients with a history of heart ,liver and Renal failure ,hypertension,diabetes&#xD;
             mellitus or arteriosclerosis; and any allergy to drugs used in the study.&#xD;
&#xD;
          -  Patients with the urinary diseases, such as kidney, ureteral calculi and tumors,&#xD;
             prostatic hypertrophy.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>the First Hospital of China Medical University</name>
      <address>
        <city>Shenyang</city>
        <state>Liaoning</state>
        <zip>110001</zip>
        <country>China</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>November 2021</verification_date>
  <study_first_submitted>April 18, 2019</study_first_submitted>
  <study_first_submitted_qc>April 20, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">April 23, 2019</study_first_posted>
  <last_update_submitted>November 5, 2021</last_update_submitted>
  <last_update_submitted_qc>November 5, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 12, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>China Medical University, China</investigator_affiliation>
    <investigator_full_name>Wen-fei Tan</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Thyroid Nodule</mesh_term>
    <mesh_term>Cholecystolithiasis</mesh_term>
    <mesh_term>Cholelithiasis</mesh_term>
    <mesh_term>Gallstones</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pharmaceutical Solutions</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

